EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

The Lancet HIV

ISSN 2352-3018 · Elsevier BV

Latest articles

  1. Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study

    Beatriz Grinsztejn, Thiago Silva Torres, Brenda Hoagland, Carolina Coutinho, Mayara Secco Torres Silva, Iuri Costa Leite, Marcelo Cunha, Monica Derrico, Emilia M Jalil, Sandra Wagner Cardoso, Roberta Trefiglio, Alessandro Farias, Maria Paula G Mourão, José Valdez Madruga, Josué N de Lima, Ronaldo Zonta, Gabrielle O’Malley, Julio Moreira, Keila Simpson, Alex R Rinehart, Nanlesta Pilgrim, Anna Hellstrom, Anne-Isabelle Cameron, Paula Mendes Luz, Raphael J Landovitz, Marcos Benedetti, Cristina Pimenta, Ronaldo Ismério Moreira, Valdilea Gonçalves Veloso, Débora Marra Faber Barreto, Sandro Nazer, Jessica Rodrigues, Carla de Barcellos Rocha, Flavia Lessa, Cristina Jalil, Laylla Monteiro, Josias Freitas, Toni Araújo, Eduardo Carvalheira, Daniel R.B. Bezerra

    Published: 2026-11DOI: 10.1016/s2352-3018(26)00201-8

  2. HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial

    Linda-Gail Bekker, Dhayendre Moodley, Dazon Dixon Diallo, Ishana Harkoo, Godfrey Kigozi, Noah Kiwanuka, Cheryl E Louw, Moelo Malahleha, Lillian Mworeko, Thesla Palanee-Phillips, Ravindre Panchia, Nishanta Singh, Sarah B Puryear, Priyanka Arora, Jared M Baeten, Andrea Brown, Christoph C Carter, Marjorie Imperial, John Ling, Renu Singh, Pamela Wong, Moupali Das, Flavia Matovu Kiweewa

    Published: 2026-09DOI: 10.1016/s2352-3018(26)00112-8

  3. The Lancet HIV Commission on ageing and HIV: a global perspective

    Amy C Justice, Keri N Althoff, A Mark Clarfield, Brenda Crabtree Ramirez, Nathan Ford, Mary-Anne Hartley, Jepchirchir Kiplagat, Grace C Y Lui, Aggrey S Semeere, Marco Vitoria, Stephen Watiti, Tristan J Barber, Till W Barnighausen, Marta Boffito, Mark Brennan-Ing, Jessica Castilho, Stephen R Connor, Claudia Cortes, Giovanni Guaraldi, Meredith Greene, Beatriz Grinsztejn, Catherine Godfrey, Workegegnehu Hailu, Virgilio A Hernandez Ruiz, Javier Hourcade Bellocq, Vanessa Johnson, John Joska, Parastu Kasaie, Oageng Moseki, Nadia Naous, Joel Negin, Daniel Ochieng, Dorothy Onyango, Nicoletta Policek, Yvette Raphael, Julia Rohr, Anat Rosenthal, Enid J Schatz, Melissa C Schnure, Kailey R Seiler

    Published: 2026-08DOI: 10.1016/s2352-3018(26)00058-5

  4. Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial

    Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, Simon Collins, Marcilio Fumagalli, Emanuela Falaschetti, Mohammed Altaf, Timothy Tipoe, Piyumika Godakandaarachi, Julie Fox, Alison Uriel, Amanda Clarke, Sabine Kinloch-de Loes, Sarah Pett, Marta Boffito, Gary Whitlock, Ole S Søgaard, Kyle Ring, Irvine Mangawa, Jesal Gohil, Tamara Elliott, Henrik Nielsen, Jesper Damsgaard Gunst, Chloe Orkin, Rebecca Sutherland, Lisa Hamzah, Paola Cicconi, Graham P Taylor, Jacquie Ujetz, Ishrat Jahan, Helen Brown, Nicola Robinson, Stephen Fletcher, Hanna Box, Kelly E Seaton, Georgia D Tomaras, Margaret E Ackerman, Joshua A Weiner, Anna Kaczynska, Cintia Bittar

    Published: 2026-08DOI: 10.1016/s2352-3018(26)00059-7

  5. Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

    Eric G Meissner, Moti Ramgopal, Peter J Ruane, William Sanchez, Gordon Crofoot, Jean-Pierre Routy, Cynthia Brinson, Edwin DeJesus, Claudia T Martorell, Marcus Tellez, Yoshiyuki Yokomaku, Mark O’Reilly, Sergio Lupo, Sven Schellberg, Jezer I Lezama-Mora, BumSik Chin, Keith Aizen, Michelle L D’Antoni, Hailin Huang, Kwad Mponponsuo, Jairo M Montezuma-Rusca, Peter Sklar, Martin Rhee, Chien-Ching Hung, Carlos Adon Moreta, Ogechika Alozie, Jonathan Angel, Andrea Antinori, Shauna Applin, Alejandro Arenas-Pinto, Paul Benson, Mezgebe Berhe, Johannes Bogner, Paolo Bonfanti, Indira Brar, Cynthia Brinson, Pedro Cahn, Antonella Castagna, Shu-Hsing Cheng, Bumsik Chin

    Published: 2026-08DOI: 10.1016/s2352-3018(26)00078-0

  6. Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial

    Jürgen K Rockstroh, Sheetal Kassim, Roger Paredes, Christopher Bettacchi, Gary Sinclair, Anchalee Avihingsanon, Nelly Mugo, Jean-Michel Molina, Brenda Crabtree Ramírez, Hiroyuki Gatanaga, Yayun Xu, Stephanie O Klopfer, Tracy L Diamond, Mary Vesnesky, Luisa M Stamm, Michelle C Fox, Mary L Pisculli

    Published: 2026-07DOI: 10.1016/s2352-3018(26)00033-0

  7. Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus

    Tommaso Clemente, Arjen J Stam, Olof Elvstam, Anna Maria Geretti, Richard Harrigan, Milosz Parczewski, Nicola E Mackie, Vincenzo Spagnuolo, Marije Hofstra, Francois Venter, Daniel R Kuritzkes, Josep M Llibre, Robert W Shafer, Jonathan Schapiro, Esteban Martinez, Cissy Kityo-Mutuluuza, Monique Nijhuis, Per Björkman, Charlotte Charpentier, Simon Collins, Huldrych F Günthard, Diego Cecchini, Antonella Castagna, Nele Brusselaers, Annemarie MJ Wensing, Diego Cecchini, Anthony D Kelleher, Katharina Grabmeier-Pfistershammer, Linos Vandekerckhove, Ricardo S Diaz, Ivailo Alexiev, Joseph Fokam, Gary Rubin, Richard Harrigan, Wai S Leung, Snježana Židovec-Lepej, Leondios G Kostrikis, Jannik Fonager, Nina Weis, Inka J Aho

    Published: 2026-07DOI: 10.1016/s2352-3018(26)00107-4

  8. Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial

    Adeodata R Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, Cissy Kityo, Abraham Siika, Moherndran Archary, Alexandra Green, Lungile Jafta, George Patrick Akabwai, Hilda Angela Mujuru, Henry Mugerwa, Cecilia Kiilu, Rosie Mngqibisa, Janet Seeley, Rashidah Nazzinda, Naomi Apoto, Simon Walker, David Burger, Carlo Giaquinto, Resty Babirye Okello, Godfrey Musoro, Charity Wambui, Tiyara Arumugam, Magda Conway, Nadine Van Looy, Annabelle South, Alasdair Bamford, Margaret J Thomason, Deborah Ford, Sarah L Pett, Sarah Pett, Deborah Ford, Margaret Thomason, Alasdair Bamford, Ellen White, Jessica Kirk, Angus Jennings, Helen Ainscough, Rebecca Dodds, Molly Bush

    Published: 2026-06DOI: 10.1016/s2352-3018(25)00326-1

  9. Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial

    Roland Landman, Lambert Assoumou, Sidonie Lambert-Niclot, Karine Amat, Christine Katlama, Clotilde Allavena, Karine Lacombe, Olivier Bouchaud, Geoffroy Liegeon, Jade Ghosn, Severine Gibowski, Jean-Claude Alvarez, Emuri Abe, Jacqueline Capeau, Soraya Fellahi, Salima Barkat, Jean-Jacques Parienti, Laurence Morand-Joubert, Pierre De Truchis, Firouzé BANI-SADR, Gilles FORCE, Amélie CHABROL, Fabienne CABY, Claudine DUVIVIER, Myriam DIEMER, Benoît CAZENAVE, Stéphanie LANDOWSKI, Gilles PIALOUX, Nicolas VIGNIER, Sophie ABGRALL, Juliette PAVIE, Dominique SALMON-CERON, David ZUCMAN, Romain PALICH, Bénédicte LEFEBVRE, Jean-Michel MOLINA, André CABIE, Philippe MORLAT, Didier NEAU, Claire GENET

    Published: 2026-06DOI: 10.1016/s2352-3018(26)00012-3

  10. Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE

    Emma M Kileel, Carlos D Malvestutto, Markella V Zanni, Emma Davies-Smith, Carl J Fichtenbaum, Jordan E Lake, Janet Lo, Judith A Aberg, Esteban Martinez, Kunjal Patel, Gerald S Bloomfield, Sarah M Chu, Aya Awwad, Marissa R Diggs, Alex B Lu, Sara H Bares, Daniel Berrner, Marek Smieja, Nwora Lance Okeke, Princy Kumar, Esau João, Judith S Currier, Michael T Lu, Matthew P Fox, Alana T Brennan, Pamela S Douglas, Steven K Grinspoon, Heather J Ribaudo

    Published: 2026-05DOI: 10.1016/s2352-3018(25)00354-6

  11. Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

    Triin Umbleja, Mohammad U Zafar, Sara McCallum, Arijeet K Gattu, Markella V Zanni, Gerald S Bloomfield, Carlos D Malvestutto, Carl J Fichtenbaum, Judith S Currier, Craig A Sponseller, Marissa R Diggs, Sarah M Chu, Alex B Lu, Marshall J Glesby, Jack T Stapleton, Michael Frank, Kim-Lien Nguyen, Rachel A Bender Ignacio, Win Min Han, Pamela S Douglas, Judith A Aberg, Heather J Ribaudo, Steven K Grinspoon

    Published: 2026-05DOI: 10.1016/s2352-3018(26)00031-7

Volumes

2026 · 1652025 · 1842024 · 1782023 · 1802022 · 1932021 · 1532020 · 1922019 · 2052018 · 1812017 · 1422016 · 1372015 · 1412014 · 30

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.